Login to Your Account



Search

Search results

Clinic roundup

Aegerion Pharmaceuticals Inc. , of Cambridge, Mass., said patient enrollment was initiated in Japan in a phase III trial of lomitapide as an adjunct treatment to reduce low-density lipoprotein cholesterol (LDL-C) in Japanese patients with homozygous ...

BioWorld Today - Staff - 2014-04-10 00:00 - 0 comments - 0 attachments

Clinic Roundup

• Advanced Cell Technology Inc. , of Marlborough, Mass., said the first subject in the third dosage cohort was injected with 150,000 human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells in its European Phase I tri ...

BioWorld Today - Staff - 2013-04-24 00:00 - 0 comments - 0 attachments

Clinic roundup

Oncolytics Biotech Inc. , of Calgary, Alberta, reported additional data from its phase III REO 018 study testing Reolysin in combination with carboplatin and paclitaxel in patients with second-line, platinum-refractory, taxane-naïve head and nec ...

BioWorld Today - Staff - 2014-04-09 00:00 - 0 comments - 0 attachments

Clinic roundup

Sangamo Biosciences Inc. , of Richmond, Calif., presented data from all dose cohorts in ongoing clinical trials (SB-728-1101 and SB-728-902 Cohort 5) of SB-728-T, which is being developed for the functional control of HIV/AIDS. (BioWorld-Tod ...

BioWorld Today - Staff - 2013-12-09 01:00 - 0 comments - 0 attachments

Clinic roundup

Pacira Pharmaceuticals Inc. announced additional phase III data supporting the safety and efficacy of (bupivacaine liposome injectable suspension) to achieve a femoral nerve block in patients undergoing total knee arthroplasty. (BioWorld-To ...

BioWorld Today - Staff - 2014-04-08 00:00 - 0 comments - 0 attachments

Clinic roundup

Noxxon Pharma AG , of Berlin, said phase IIa proof-of-concept data from the emapticap pegol (NOX-E36) trial in diabetic nephropathy were presented at the ISN Nexus Symposium in Bergamo, Italy. (BioWorld-Today-2014-04-07) ...

BioWorld Today - Staff - 2014-04-07 00:00 - 0 comments - 0 attachments

Clinic roundup

Gilead Sciences Inc. , of Foster City Calif., said positive top-line results from a phase III trial evaluating Sovaldi (sofosbuvir) in combination with ribavirin for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection in Japan put i ...

BioWorld Today - Staff - 2014-04-04 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Dompe Group , of Milan, said it started a phase Ib/II study to assess the safety and potential efficacy of recombinant human nerve growth factor (rhNGF) eye drops in two doses vs. placebo. (BioWorld-Today-2014-04-04) ...

BioWorld Today - Staff - 2014-04-04 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Bayer HealthCare Pharmaceuticals Inc. , of Whippany, N.J., began enrollment in a trial studying Xofigo (radium Ra 223 dichloride) injection in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mil ...

BioWorld Today - Staff - 2014-04-03 00:00 - 0 comments - 0 attachments

Clinic roundup

Cardiocell LLC , of San Diego, received investigational new drug approval from the FDA for a phase IIa study using its allogeneic stem cell therapy to treat patients with chronic heart failure (CHF). (BioWorld-Today-2014-04-03) ...

BioWorld Today - Staff - 2014-04-03 00:00 - 0 comments - 0 attachments